Latest filing published 06 Sept 2024 for Ascelia Pharma AB, €13k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Kibegeon: trading record in brief
Kibegeon discloses dealings in Ascelia Pharma AB to Finansinspektionen. In total, 4 filings cover trades dated from 14 January 2021 to 3 September 2024.
Every open-market trade on record is a sale: 1 sale worth €13k. So far in 2024, the count stands at no purchases and 1 sale.
The newest entry dates from 6 September 2024: an open-market sale of €13k, in Ascelia Pharma AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Kibegeon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 913,545 shares@ SEK 0.165224.4% of flowTeckningsrätt/UniträttISIN SE0010573113FI:csv-1c3065f3ca60f1d19721
- 150,000 shares0Teckningsrätt/UniträttISIN SE0022725453FI:csv-d8739f9494c08ad561c4
- 92,304 shares@ SEK 5.0775.6% of flowBTU (betald tecknad unit)ISIN SE0022725461FI:csv-9fb84a7b9edb5e89b788
- 112,500 shares0AktieISIN SE0010573113FI:csv-67b0d26fef9d9a2c0537
4 of 4 declarations